Form 10-K for the Fiscal Year Ended December 31, 2021
Your disclosure on page F-12 indicates that you operate principally in the United States, India, and Ireland. Please revise future filings to disclose the amount of revenue and longlived assets that are attributed to the United States as well as any individual foreign country that is material. Refer to ASC 280-10-50-41.
Over 99% of our consolidated net revenue for the years ended December 31, 2021 and 2020 was attributed to the United States. In response to the Staff’s comment, we expect to prospectively revise the segment disclosures in our 2022 Annual Report on Form 10-K as follows:Read in the reply
Net revenue from external customers is attributed to countries based on the location of the product shipment.Rest of the answer
For the years ended December 31, 2022, 2021, and 2020, net revenue from external customers attributed to foreign countries was immaterial.
Should net revenue from external customers attributed to foreign countries become material in future years, we will update our disclosures.
Amneal
Pharmaceuticals, 400 Crossing Boulevard, 3rd Floor, Bridgewater, NJ 08807
P.
908.947.3120 F. 908.947.3146 www.amneal.com
With respect to long-lived assets, we will prospectively revise the segment disclosures in our 2022 Annual Report on Form 10-K to separately present our long-lived assets in the United States, India and Ireland. The disclosure will be substantially in the form of the disclosure set forth below and will be updated, as appropriate, as of December 31, 2022.
Long-lived assets, which are comprised of property, plant and equipment, net and operating and financing lease right-of-use assets, are attributed based on physical location. Long-lived assets by country were as follows (in thousands):
December 31,
2021
2020
United States
$
388,818
416,637
India
189,885
121,046
Ireland
60,300
67,027
$ 639,003
$ 604,710
ASC
280-10-50-39 requires entity-wide segment disclosures of geographic revenue and long-lived assets in annual reporting periods only; accordingly, the foregoing changes will only be made to our Annual Reports on Form 10-K.
First report after the company's reply of Aug 4, 2022: 10-Q filed Aug 8, 2022 ↗, against the 10-Q filed May 6, 2022 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
Also in this review: closing letter, 2022-08-05